Jürgen Floege
Jürgen Floege
Professor of Nephrology, RWTH University of Aachen
Verified email at
Cited by
Cited by
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of …
GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ...
Annals of the rheumatic diseases 71 (11), 1771-1782, 2012
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
C Schäfer, A Heiss, A Schwarz, R Westenfeld, M Ketteler, J Floege, ...
The Journal of clinical investigation 112 (3), 357-366, 2003
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study
M Ketteler, P Bongartz, R Westenfeld, JE Wildberger, AH Mahnken, ...
The Lancet 361 (9360), 827-833, 2003
Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options
J Jankowski, J Floege, D Fliser, M Böhm, N Marx
Circulation 143 (11), 1157-1172, 2021
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis
EVOLVE Trial Investigators
New England Journal of Medicine 367 (26), 2482-2494, 2012
KDIGO 2021 clinical practice guideline for the management of glomerular diseases
BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ...
Kidney international 100 (4), S1-S276, 2021
Renal fibrosis: novel insights into mechanisms and therapeutic targets
P Boor, T Ostendorf, J Floege
Nature Reviews Nephrology 6 (11), 643-656, 2010
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis
P Raggi, GM Chertow, PU Torres, B Csiky, A Naso, K Nossuli, M Moustafa, ...
Nephrology Dialysis Transplantation 26 (4), 1327-1339, 2011
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
J Floege, J Kim, E Ireland, C Chazot, T Drueke, A de Francisco, ...
Nephrology Dialysis Transplantation 26 (6), 1948-1955, 2011
Intensive supportive care plus immunosuppression in IgA nephropathy
T Rauen, F Eitner, C Fitzner, C Sommerer, M Zeier, B Otte, U Panzer, ...
New England Journal of Medicine 373 (23), 2225-2236, 2015
Renal injury from angiotensin II-mediated hypertension.
RJ Johnson, CE Alpers, A Yoshimura, D Lombardi, P Pritzl, J Floege, ...
Hypertension 19 (5), 464-474, 1992
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
K Kiryluk, Y Li, F Scolari, S Sanna-Cherchi, M Choi, M Verbitsky, D Fasel, ...
Nature genetics 46 (11), 1187-1196, 2014
Recruitment of podocytes from glomerular parietal epithelial cells
D Appel, DB Kershaw, B Smeets, G Yuan, A Fuss, M Elger, W Kriz, ...
Journal of the American Society of Nephrology 20 (2), 333-343, 2009
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model
J Floege, MW Burns, CE Alpers, A Yoshimura, P Pritzl, K Gordon, ...
Kidney international 41 (2), 297-309, 1992
Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial
J Lv, H Zhang, MG Wong, MJ Jardine, M Hladunewich, V Jha, ...
Jama 318 (5), 432-442, 2017
Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases
BH Rovin, SG Adler, J Barratt, F Bridoux, KA Burdge, TM Chan, HT Cook, ...
Kidney international 100 (4), 753-779, 2021
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes
TM Coimbra, U Janssen, HJ Gröne, T Ostendorf, U Kunter, H Schmidt, ...
Kidney international 57 (1), 167-182, 2000
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
R Coppo, S Troyanov, S Bellur, D Cattran, HT Cook, J Feehally, ...
Kidney international 86 (4), 828-836, 2014
Decoding myofibroblast origins in human kidney fibrosis
C Kuppe, MM Ibrahim, J Kranz, X Zhang, S Ziegler, J Perales-Patón, ...
Nature 589 (7841), 281-286, 2021
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor.
RJ Johnson, EW Raines, J Floege, A Yoshimura, P Pritzl, C Alpers, ...
The Journal of experimental medicine 175 (5), 1413-1416, 1992
The system can't perform the operation now. Try again later.
Articles 1–20